◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Sawai Group Holdings Co., Ltd. (4887) Financial History

Name: Sawai Group Holdings Co., Ltd. (4887) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Sawai Group Holdings Co., Ltd. (4887) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Osaka, Japan with about 3,630 employees. Its market capitalization is roughly JPY 184 billion. In the fiscal year ended 2026-03-31, 4887 reported JPY 201.7B in revenue and JPY 10.4B in net income.

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

Interactive charts & full statements →

4887 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 201.7B	JPY 189.0B	JPY 176.9B	JPY 163.7B
Gross Profit	JPY 58.8B	JPY 56.4B	JPY 54.3B	JPY 50.3B
Operating Income (EBIT)	JPY 15.9B	JPY 4.1B	JPY 18.6B	JPY 16.1B
Net Income	JPY 10.4B	JPY 12.0B	JPY 13.7B	JPY 12.7B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4887 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 6.2B)	(JPY 6.1B)	(JPY 5.7B)	(JPY 5.7B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4887 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 359.9B	JPY 354.6B	JPY 382.0B	JPY 364.2B	—
Total Liabilities	JPY 181.4B	JPY 180.8B	JPY 164.0B	JPY 151.4B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4887 viewer.

4887 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

1276 · Jiangsu Hengrui Pharmaceuticals Co.,Ltd — $382 billion
4540 · Tsumura & Co. — $280 billion
4516 · Nippon Shinyaku Co., Ltd. — $242 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion
4553 · Towa Pharmaceutical Co., Ltd. — $182 billion
4547 · Kissei Pharmaceutical Co., Ltd. — $171 billion
4521 · Kaken Pharmaceutical Co., Ltd. — $151 billion
TEVA · Teva Pharmaceutical Industries Limited — ₪125 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4886 All “0-9” companies 4901 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.